Registration Options

Activity Dates: 12/19/2019 - 12/19/2022

Target Audience

This activity is designed to meet the educational needs of pharmacists and other health care professionals who are interested in or managing the medication of patients with OUD.

Session Summary

During this session, participants will understand the mechanism of action and dosing for buprenorphine/naloxone, methadone, and naltrexone. In addition, the learner will be able to discuss the American Society of Addiction Medicine (ASAM) levels of care, and recommend non-pharmacologic treatments for a patient being treated for OUD.


Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Complete the pre-test before starting the activity.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor.

Participants in this course must complete an examination and achieve a score of 70% or greater. Up to two exam attempts are provided to each participant. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at

Faculty Information and Disclosures

Cassandra Davis, PharmD, BCPS, BCPP

View biographical information and disclosures

Learning Objectives

  1. Explain the basic mechanism of action, dosing and dosage forms, adverse effects, monitoring parameters, and patient considerations for buprenorphine/naloxone, methadone, and naltrexone.
  2. Describe the American Society of Addiction Medicine (ASAM) levels of care and appropriate use in clinical practice. 
  3. Develop a care plan for a patient prescribed buprenorphine/naloxone, methadone, or naltrexone for the outpatient treatment of OUD. 
  4. Recommend non-pharmacologic treatments and wrap-around services for a patient being treated for OUD.

Continuing Education Credit and Disclosures

Activity Dates: 12/19/2019 - 12/19/2022
ACPE Contact Hours: 2
ACPE Number: 0284-0000-19-074-H08-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Grant Support

This activity is supported by an educational grant from Alkermes, Inc.
25 Years!